Vera Therapeutics, Inc.

NasdaqGM:VERA Stock Report

Market Cap: US$2.7b

Vera Therapeutics Dividends and Buybacks

Dividend criteria checks 0/6

Vera Therapeutics does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-11.1%

Buyback Yield

Total Shareholder Yield-11.1%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Vera Therapeutics: Strong Data In IgAN, But We May Be Too Late

Dec 22

Is Vera Therapeutics (NASDAQ:VERA) A Risky Investment?

Oct 07
Is Vera Therapeutics (NASDAQ:VERA) A Risky Investment?

Vera: Potential First Of Atacicept As A B-Cell Modulator For IgAN Patients

Oct 04

Vera Therapeutics' Atacicept: A Potential Game-Changer In IgA Nephropathy

Jul 22

Is Vera Therapeutics (NASDAQ:VERA) Using Debt In A Risky Way?

Jul 05
Is Vera Therapeutics (NASDAQ:VERA) Using Debt In A Risky Way?

Vera Therapeutics: Soaring On IgAN Data, But Full Approval A Distant Prospect

Jan 25

Vera Therapeutics: Under The Radar IgAN Player Has Much To Prove

Sep 06

Vera Therapeutics GAAP EPS of -$0.55 beats by $0.17

Aug 10

Companies Like Vera Therapeutics (NASDAQ:VERA) Are In A Position To Invest In Growth

Feb 16
Companies Like Vera Therapeutics (NASDAQ:VERA) Are In A Position To Invest In Growth

Vera: Biotech With 3 Mid-Stage Programs With Potential For Success

Jan 19

Vera Therapeutics: Surprising Pivot To A Kidney Disease Drug Looks Like A Long Shot

Jan 07

We Think Vera Therapeutics (NASDAQ:VERA) Can Afford To Drive Business Growth

Oct 25
We Think Vera Therapeutics (NASDAQ:VERA) Can Afford To Drive Business Growth

Vera Therapeutics soars 16% on three new favorable view from analysts

Jun 08

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if VERA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VERA's dividend payments have been increasing.


Dividend Yield vs Market

Vera Therapeutics Dividend Yield vs Market
How does VERA dividend yield compare to the market?
SegmentDividend Yield
Company (VERA)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.5%
Industry Average (Biotechs)2.5%
Analyst forecast (VERA) (up to 3 years)n/a

Notable Dividend: Unable to evaluate VERA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VERA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate VERA's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as VERA has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 02:07
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vera Therapeutics, Inc. is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pete StavropoulosCantor Fitzgerald & Co.
Liisa BaykoEvercore ISI
Vamil DivanGuggenheim Securities, LLC